297(3): 1325 Simenhoff ML, Ginn HE, Teschan PE
(1) Overview Ipamorelin is the first synthetic GHS that appears highly selective and may have the potential to augment the production of hGH without affecting other pituitary hormones such as prolactin or adrenocorticotropic hormone (ACTH)
Ipamorelin also has a good safety profile, and is similar to Sermorelin, but has a different mechanism of action in helping increase Growth Hormone
"They lower systemic inflammation levels and reduce the risk of worsening heart failure events
suggest that among the anti-diabetic agents, only sulfonylurea, and not insulin, was significantly associated with higher risk of TC (Tse and ng, 2012)
The treatment of pulmonary diseases and respiratory-related conditions with inhaled (nebulized or aerosolized) glutathione